Trending Medical and health breaking news FDA Approves New Myasthenia Gravis Drug

Trending Medical and well being breaking information FDA Approves New Myasthenia Gravis Drug

The US Food and Drug Administration (FDA) has approved efgartigimod (Vyvgart, argenx), a first-in-class, targeted therapy for adults with generalized myasthenia gravis (gMG) who test positive for the antiacetylcholine receptor (AChR) antibody. “There are significant unmet medical needs for people living with myasthenia gravis, as with many other rare diseases,” Billy Dunn, MD, director, Office…